Article Versions Notes

da Silva CFA, Camalhonte SO, de Oliveira Almeida M, Araujo SC, Sannomiya M, Lago JHG, Honorio KM. Effect of the N501Y Mutation on Ligands Complexed with SARS-CoV-2 RBD: Insights on Potential Drug Candidates for COVID-19. Drugs and Drug Candidates. 2023; 2(2):433-458. https://doi.org/10.3390/ddc2020022

da Silva, Camila Fonseca Amorim, Samanta Omae Camalhonte, Michell de Oliveira Almeida, Sheila Cruz Araujo, Miriam Sannomiya, João Henrique Ghilardi Lago, and Kathia Maria Honorio. 2023. "Effect of the N501Y Mutation on Ligands Complexed with SARS-CoV-2 RBD: Insights on Potential Drug Candidates for COVID-19" Drugs and Drug Candidates 2, no. 2: 433-458. https://doi.org/10.3390/ddc2020022

da Silva, C. F. A., Camalhonte, S. O., de Oliveira Almeida, M., Araujo, S. C., Sannomiya, M., Lago, J. H. G., & Honorio, K. M. (2023). Effect of the N501Y Mutation on Ligands Complexed with SARS-CoV-2 RBD: Insights on Potential Drug Candidates for COVID-19. Drugs and Drug Candidates, 2(2), 433-458. https://doi.org/10.3390/ddc2020022